Company Name:Retrophin, Inc.
CEO: Eric Dube

Sector: Health Technology
Industry:Biotechnology

Exchange: NASDAQ

Country: US

Description: Retrophin, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. Its products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 8, 2008 and is headquartered in San Diego, CA.


Key numbers

Market Capitalization:871743120
Shares Outstanding: 43155600
Float: 42656419
Next Earning Date:
TTm EPS: -2.4567
TTm Dividend Rate:
200 days moving average:15.31
50 days moving average: 18.13
One day percent Change: -3.91



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,